Tim Walz Visits Karolinska Institutet
This week, Minnesota Governor Tim Walz visited Karolinska Institutet together with a delegation from Minnesota for a strategic forum on research, healthcare, innovation and life sciences.
Deputy Vice-President Martin Bergö welcomed Governor Walz and the delegation and highlighted the longstanding collaboration between Karolinska Institutet and Mayo Clinic. The partnership is now entering a new phase in which research, education, healthcare, innovation and entrepreneurship are being integrated more closely, with the aim of translating advances into tangible benefits for patients more rapidly.
– When our researchers work together, the quality of the research improves. Together, we can make the next chapter of the collaboration between Karolinska Institutet and Mayo Clinic more ambitious, more innovative and more consequential for our respective institutions, for society and, above all, for patients, Martin Bergö said in his opening remarks.
In his presentation, Tim Walz emphasized the strong similarities between Minnesota and Sweden. He highlighted shared commitments to education, research and science, citing childhood immunization programmes as a concrete example of a common approach to public health. According to Walz, these shared values provide a strong foundation for continued and deeper collaboration between Minnesota and Sweden.
The concluding panel discussion focused on how research findings can be translated into innovations and new treatments, and on the conditions required for research-based ideas to be developed and ultimately reach patients. The discussion addressed challenges related to financing in the early stages of development, the commercialization of research findings and Sweden’s teacher’s exemption. The Minnesota delegation also highlighted the region’s strong innovation ecosystem and the close links between academia, healthcare providers, investors and industry. The delegation further noted that medical technology innovations in Minnesota often obtain approval from the US Food and Drug Administration (FDA) more rapidly than in many other parts of the United States.
The collaboration between Karolinska Institutet and Mayo Clinic began more than 30 years. Over the years, more than 3,000 students, researchers and staff members have participated in exchanges within the framework of the collaboration.
The meeting at Karolinska Institutet provided an opportunity to look ahead and discuss how collaboration between Minnesota and Sweden could be further developed. By integrating research, healthcare and innovation, there is considerable potential to develop new solutions that benefit patients and society.
The panel comprised:
- Katherine Arendt, Mayo Clinic
- Sophie Erhardt, Karolinska Institutet
- Johan Weigelt, KI Innovation
- Malin Nilsson, Inossia
- Björn Nordlund, MediTuner / Karolinska Institutet